281 related articles for article (PubMed ID: 15907761)
1. Polyamine transport in parasites: a potential target for new antiparasitic drug development.
Reguera RM; Tekwani BL; Balaña-Fouce R
Comp Biochem Physiol C Toxicol Pharmacol; 2005 Feb; 140(2):151-64. PubMed ID: 15907761
[TBL] [Abstract][Full Text] [Related]
2. Polyamine biosynthetic enzymes as drug targets in parasitic protozoa.
Heby O; Roberts SC; Ullman B
Biochem Soc Trans; 2003 Apr; 31(2):415-9. PubMed ID: 12653650
[TBL] [Abstract][Full Text] [Related]
3. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis.
Heby O; Persson L; Rentala M
Amino Acids; 2007 Aug; 33(2):359-66. PubMed ID: 17610127
[TBL] [Abstract][Full Text] [Related]
4. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases.
Casero RA; Marton LJ
Nat Rev Drug Discov; 2007 May; 6(5):373-90. PubMed ID: 17464296
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of polyamine derivative compounds against Leishmania infantum promastigotes and axenic amastigotes.
Tavares J; Ouaissi A; Lin PK; Tomás A; Cordeiro-da-Silva A
Int J Parasitol; 2005 May; 35(6):637-46. PubMed ID: 15862577
[TBL] [Abstract][Full Text] [Related]
6. Functional consequences of perturbing polyamine metabolism in the malaria parasite, Plasmodium falciparum.
Clark K; Niemand J; Reeksting S; Smit S; van Brummelen AC; Williams M; Louw AI; Birkholtz L
Amino Acids; 2010 Feb; 38(2):633-44. PubMed ID: 19997948
[TBL] [Abstract][Full Text] [Related]
7. The cell cycle of parasitic protozoa: potential for chemotherapeutic exploitation.
Hammarton TC; Mottram JC; Doerig C
Prog Cell Cycle Res; 2003; 5():91-101. PubMed ID: 14593704
[TBL] [Abstract][Full Text] [Related]
8. Targeting polyamines of parasitic protozoa in chemotherapy.
Müller S; Coombs GH; Walter RD
Trends Parasitol; 2001 May; 17(5):242-9. PubMed ID: 11323309
[TBL] [Abstract][Full Text] [Related]
9. Significance of targeting polyamine metabolism as an antineoplastic strategy: unique targets for polyamine analogues.
Casero RA; Frydman B; Stewart TM; Woster PM
Proc West Pharmacol Soc; 2005; 48():24-30. PubMed ID: 16416654
[TBL] [Abstract][Full Text] [Related]
10. Assessing the polyamine metabolism of Plasmodium falciparum as chemotherapeutic target.
Müller IB; Das Gupta R; Lüersen K; Wrenger C; Walter RD
Mol Biochem Parasitol; 2008 Jul; 160(1):1-7. PubMed ID: 18455248
[TBL] [Abstract][Full Text] [Related]
11. Polyamine metabolism as chemotherapeutic target in protozoan parasites.
Bacchi CJ; Yarlett N
Mini Rev Med Chem; 2002 Dec; 2(6):553-63. PubMed ID: 12370040
[TBL] [Abstract][Full Text] [Related]
12. Scientific hypothesis: a new strategy for the design of anti-protozoal drugs--DNA polymerase as a drug target.
Biñas M; Johnson AM
Appl Parasitol; 1994 Sep; 35(3):157-68. PubMed ID: 7951392
[TBL] [Abstract][Full Text] [Related]
13. Targeting DHFR in parasitic protozoa.
Anderson AC
Drug Discov Today; 2005 Jan; 10(2):121-8. PubMed ID: 15718161
[TBL] [Abstract][Full Text] [Related]
14. Polyamine catabolism: target for antiproliferative therapies in animals and stress tolerance strategies in plants.
Tavladoraki P; Cona A; Federico R; Tempera G; Viceconte N; Saccoccio S; Battaglia V; Toninello A; Agostinelli E
Amino Acids; 2012 Feb; 42(2-3):411-26. PubMed ID: 21874532
[TBL] [Abstract][Full Text] [Related]
15. Novel agmatine analogue, gamma-guanidinooxypropylamine (GAPA) efficiently inhibits proliferation of Leishmania donovani by depletion of intracellular polyamine levels.
Singh S; Jhingran A; Sharma A; Simonian AR; Soininen P; Vepsalainen J; Khomutov AR; Madhubala R
Biochem Biophys Res Commun; 2008 Oct; 375(1):168-72. PubMed ID: 18692480
[TBL] [Abstract][Full Text] [Related]
16. Polyamine homoeostasis as a drug target in pathogenic protozoa: peculiarities and possibilities.
Birkholtz LM; Williams M; Niemand J; Louw AI; Persson L; Heby O
Biochem J; 2011 Sep; 438(2):229-44. PubMed ID: 21834794
[TBL] [Abstract][Full Text] [Related]
17. Polyamine metabolism in the Microsporidia.
Bacchi CJ; Yarlett N; Weiss LM
Biochem Soc Trans; 2003 Apr; 31(2):420-3. PubMed ID: 12653651
[TBL] [Abstract][Full Text] [Related]
18. Polyamine modulation of iron uptake in CHO cells.
Gaboriau F; Kreder A; Clavreul N; Moulinoux JP; Delcros JG; Lescoat G
Biochem Pharmacol; 2004 May; 67(9):1629-37. PubMed ID: 15081862
[TBL] [Abstract][Full Text] [Related]
19. New mechanisms of drug resistance in parasitic protozoa.
Borst P; Ouellette M
Annu Rev Microbiol; 1995; 49():427-60. PubMed ID: 8561467
[TBL] [Abstract][Full Text] [Related]
20. Ornithine decarboxylase and S-adenosylmethionine decarboxylase in trypanosomatids.
Persson L
Biochem Soc Trans; 2007 Apr; 35(Pt 2):314-7. PubMed ID: 17371268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
